Performance Feedback

OTHER3 trials

Sponsors

Cereneo AG, University of California, San Francisco, University of Southern California

Conditions

Emergency DepartmentRifampicin Resistant TuberculosisStrokeTuberculosis, Pulmonary

Unknown Phase

Feedback and Rewards to Increase Motivation for Therapy in Stroke Rehabilitation

CompletedNCT02315963

Cereneo AGStroke

Start: 2016-04-30End: 2020-12-31Target: 62Updated: 2021-02-01

GeneXpert Performance Evaluation for Linkage to Tuberculosis Care

CompletedNCT03044158

University of California, San FranciscoRifampicin Resistant Tuberculosis, Tuberculosis, Pulmonary

Start: 2018-10-22End: 2022-07-31Updated: 2025-02-18

Improving Quality & Equity of Emergency Care Decisions (IQED)

WithdrawnNCT03966989

University of Southern CaliforniaEmergency Department

Start: 2021-12-31End: 2022-06-30Updated: 2021-12-20

Related Papers

Impact of a multicomponent strategy including decentralized molecular testing for tuberculosis on mortality: planned analysis of a cluster-randomized trial in Uganda.

2024-11-26

Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis

New England Journal of Medicine2021-12-2228 citations

Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB).

2020-04-2117 citations